48 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Jaguar Health Inc JAGX shares jumped 69.1 percent to $12.60 after the company announced its subsidiary, Napo Therapeutics, will receive preclinical services from the National Institute of Allergy and Infectious Diseases to develop lechlemer, a drug for cholera indication.
• ContraVir Pharmaceuticals Inc CTRV shares rose 57.1 percent to $11.00. ContraVir issued press release highlighting publication of CRV431 data from experimental model of Hep B.
• Zynerba Pharmaceuticals Inc ZYNE rose 18.4 percent to $13.71 after receiving new US patent for treatment of autism spectrum disorder with cannabidiol.
• Xynomic Pharmaceuticals Holdings, Inc. XYN climbed 18 percent to $3.5750.
• Chico's FAS, Inc. CHS shares gained 14.8 percent to $3.915. Chico's FAS reported upbeat earnings for its first quarter, while comparable sales dropped 7.0 percent during the quarter. The company also lowered its full-year sales guidance.
• Sesen Bio, Inc. SESN gained 13.2 percent to $2.1501. H.C. Wainwright upgraded Sesen Bio from Neutral to Buy and raised the price target from $1 to $3.
• Capricor Therapeutics, Inc. CAPR surged 12.7 percent to $3.3911.
• Casey's General Stores Inc CASY rose 11.7 percent to $148.64 after the company reported stronger-than-expected earnings for its fourth quarter and raised its quarterly dividend from 29 cents per share to 32 cents per share.
• Ocular Therapeutix, Inc. OCUL gained 10.5 percent to $3.59.
• Marker Therapeutics, Inc. MRKR surged 10.1 percent to $6.23.
• PolyOne Corporation POL surged 9.9 percent to $29.72 after the company raised its second-quarter adjusted earnings per share guidance from 68 cents to 72-74 cents.
• Mammoth Energy Services, Inc. TUSK gained 9.7 percent to $6.46.
• Motus GI Holdings, Inc. MOTS rose 9.2 percent to $4.16 after the company received FDA clearance to market its Pure-Vu GEN2 system.
• Foamix Pharmaceuticals Ltd. FOMX gained 9.2 percent to $2.73.
• Hemispherx Biopharma, Inc. HEB climbed 8.6 percent to $4.8436.
• Stitch Fix, Inc. SFIX gained 8.3 percent to $30.44.
• Grubhub Inc. GRUB rose 8.1 percent to $69.93 following news that Amazon will shut down its Amazon Restaurants business in the U.S.
• Turtle Beach Corporation HEAR jumped 8 percent to $10.04.
• UP Fintech Holding Limited TIGR gained 8 percent to $4.72.
• Tailored Brands, Inc. TLRD shares climbed 7.8 percent to $6.05.
• Precipio, Inc. PRPO shares rose 7.4 percent to $4.6266.
• BRP Inc. DOOO surged 7.3 percent to $35.25 after the company announced proposed terms of its $300 million substantial issuer bid.
• Intrexon Corporation XON gained 7.2 percent to $5.95.
• John Wiley & Sons, Inc. (NYSE: JW-A) surged 6.8 percent to $46.00 after reporting Q4 results.
• ArcelorMittal MT shares rose 6.7 percent to $16.97 after gaining 3.52 percent on Monday.
• ZIOPHARM Oncology Inc. ZIOP rose 6 percent to $4.4500 after the company reported the FDA clearance of IND for sleeping beauty TCR-T cell therapy trial at the NCI.
• Dollar Tree, Inc. DLTR gained 3.4 percent to $107.30 after JP Morgan upgraded the company's stock from Neutral to Overweight and announced a $122 price target.

Check out these big penny stock gainers and losers

Losers

• CymaBay Therapeutics, Inc. CBAY dipped 45.2 percent to $6.08 after the company reported data from its Phase 2b study of Seladelpar in patients with nonalcoholic steatohepatitis. Data showed reductions in liver fat were minimal and not significant compared to the placebo.
• Achieve Life Sciences, Inc. ACHV fell 34.8 percent to $2.5300 after the company reported announced positive results Tuesday from the ORCA-1 dose-selection trial of cytisinicline for smoking cessation. The primary endpoint was the reduction in daily smoking, a self-reported measure. Across all treatment arms, subjects on cytisinicline experienced a 74-80-percent median reduction in the number of cigarettes smoked over a 25-day treatment period — compared to a 62-percent reduction in the placebo arms.
• Beyond Meat, Inc. BYND fell 20.1 percent to $134.37 after rising 21.24 percent on Monday. JP Morgan downgraded Beyond Meat from Overweight to Neutral and raised the price target from $120 to $121.
• NovaBay Pharmaceuticals, Inc. NBY fell 19.7 percent to $2.49 after rising around 875 percent Monday after the company reached an agreement to sell its eye care product on Amazon.com.
• Stellar Biotechnologies Inc EDSA dropped 17.7 percent to $4.28.
• Lovesac Co LOVE fell 14.3 percent to $33.64 after the company reported worse-than-expected Q1 EPS results.
• Genfit SA GNFT dipped 14.2 percent to $20.49.
• electroCore, Inc. ECOR shares declined 13.5 percent to $1.73.
• ShockWave Medical, Inc. SWAV shares fell 11.4 percent to $58.51.
• uniQure N.V. QURE dropped 11.1 percent to $66.63.
• Evolus, Inc. EOLS shares declined 9.2 percent to $12.85.
• Intellicheck, Inc. IDN fell 9 percent to $5.69.
• FTD Companies Inc FTD shares fell 8.9 percent to $0.1700. Travertine Creek disclosed a 12 percent stake in the company.
• Pareteum Corporation TEUM shares fell 8.7 percent to $2.7401 after jumping 16.28 percent on Monday.
• Advaxis, Inc. ADXS dropped 8.6 percent to $2.5600 following Q2 results.
• GTx, Inc. ONCT fell 8.5 percent to $6.43 after falling 16.31 percent on Monday.
• Arvinas, Inc. ARVN dropped 8 percent to $18.65.
• Orion Group Holdings, Inc. ORN dipped 7.3 percent to $2.29.
• Argan, Inc. AGX fell 6.3 percent to $41.09 after the company reported worse-than-expected Q1 earnings and sales results.
• Sprint Corporation S tumbled 6.2 percent to $6.55 following reports indicating several US State Attorney Generals are preparing to file a lawsuit to block the proposed merger with T-Mobile.
• HD Supply Holdings, Inc. HDS fell 6.1 percent to $39.93. HD Supply reported upbeat earnings for its first quarter, but issued weak Q2 forecast.